Immunomodulatory activity of IR700-labelled affibody targeting HER2Justyna Mączyńska(Institute of Cancer Research), Gabriela Krämer-Marek(Institute of Cancer Research)Cell Death and DiseaseOctober 20, 202010.1038/s41419-020-03077-6Cited by 35SaveCiteExport RISWatch citationsRelated PapersChanges in<i>HER2</i>Expression in Breast Cancer Xenografts After Therapy Can Be Quantified Using PET and<sup>18</sup>F-Labeled Affibody Molecules|Journal of Nuclear Medicine|2009|97